Cabot (NYSE:CBT) Upgraded to "Buy" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Cabot from “Hold” to “Buy,” although broader analyst sentiment remains “Hold,” with two Buy ratings, four Holds and one Sell rating; the consensus price target is $89.
• Cabot reported quarterly EPS of $1.67, narrowly exceeding estimates, while revenue rose 6.4% year over year to $982 million. The company set fiscal 2026 EPS guidance of $6.15–$6.45.
• Cabot shares opened at $87.69, near the $89 consensus target, and institutional investors own a substantial 93.18% of the outstanding stock.

Cabot (NYSE:CBT - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Sunday.

Several other equities research analysts also recently weighed in on the stock. Truist Financial set a $100.00 target price on shares of Cabot in a research note on Wednesday. UBS Group cut their price objective on Cabot from $97.00 to $92.00 and set a "neutral" rating on the stock in a research report on Wednesday. Mizuho upped their price objective on Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a research report on Thursday, June 25th. Weiss Ratings reiterated a "hold (c)" rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, JPMorgan Chase & Co. boosted their target price on Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research note on Friday. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $89.00.

Cabot Stock Performance

Shares of Cabot stock opened at $87.69 on Friday. The stock has a market capitalization of $4.53 billion, a price-to-earnings ratio of 24.70, a price-to-earnings-growth ratio of 11.45 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.96. The business has a 50-day moving average of $87.92 and a 200 day moving average of $79.87. Cabot has a 12 month low of $58.33 and a 12 month high of $94.53.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. During the same period in the prior year, the firm earned $1.90 earnings per share. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, sell-side analysts forecast that Cabot will post 6.32 earnings per share for the current year.

Institutional Investors Weigh In On Cabot

Hedge funds and other institutional investors have recently modified their holdings of the company. UBS Group AG boosted its position in shares of Cabot by 3.5% during the 4th quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company's stock worth $40,708,000 after acquiring an additional 20,668 shares in the last quarter. Denali Advisors LLC purchased a new position in shares of Cabot in the 4th quarter valued at about $5,531,000. Lazard Asset Management LLC raised its position in shares of Cabot by 96.2% during the 1st quarter. Lazard Asset Management LLC now owns 43,219 shares of the specialty chemicals company's stock worth $3,255,000 after acquiring an additional 21,194 shares in the last quarter. Peregrine Capital Management LLC raised its position in shares of Cabot by 24.7% during the 4th quarter. Peregrine Capital Management LLC now owns 79,148 shares of the specialty chemicals company's stock worth $5,246,000 after acquiring an additional 15,669 shares in the last quarter. Finally, Norges Bank purchased a new stake in Cabot during the fourth quarter worth approximately $49,662,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source